High investment over advanced medical devices influences United Kingdom Renal Denervation Market growth.
According to TechSci report on, “United Kingdom Renal Denervation Market – By Region, Competition Forecast & Opportunities, 2027” United Kingdom renal denervation market may flourish with an impressive CAGR during the forecast period of 2023-2027, on the backbone of increasing number of patients suffering from hypertension. Rising instances of high blood pressure among the population drives the growth od the United Kingdom renal denervation market in the upcoming five years. Growing instances of therapy resistant hypertension may also be considered as a key growth factor for the United Kingdom renal denervation market in the next five years. The population in the United kingdom are highly inclined toward consumption of junk food and fast food. Online delivery of the food & groceries adds to the convenience of the working-class population living a highly sedentary lifestyle. Growing instances of younger population being involved with heavy alcohol consumption and smoking also fuels the growing risks of high blood pressure thereby aiding the growth of the United Kingdom renal denervation market in the future five years.
Renal denervation has shown positive results in controlling the disastrous cases of therapy resistant hypertension, and the advantages of the treatment includes permanent effect and completely avoiding the high blood pressure medications, thus are readily adapted by the patients and advised by the doctors for the procedure, that substantiates the growth of the United Kingdom renal denervation market in the forecast years though 2027F. Technological advancement in the equipment and medical devices such as development of catheter-based interventional therapies to ablate renal nerve further facilitate the growth of the United Kingdom renal denervation market in the forecast period.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on
“United Kingdom Renal denervation Market”
https://www.techsciresearch.com/report/united-kingdom-renal-denervation-market/10634.html
The United Kingdom renal denervation market is segmented by technology, product, therapeutic area, end user, competitional landscape, and regional distribution. Based on technology, the market is further segmented into ultrasound ablation, radiofrequency ablation, pharmacologic ablation, and micro-infusion. Radiofrequency ablation is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to its advantages like safety of the procedure and time efficiency. Also, ultrasound ablation is expected to register significant growth in the next five years on the backbone of high-frequency sound waves that ablates the nerves without getting in direct contact with the tissues, thus reducing injuries to the renal arteries.
By product, the market is fragmented into catheters, single electrode catheter, multi electrode catheter, RF generator, and others. Catheters are anticipated to lead the market segment and hold the largest revenue shares of the market in the upcoming five years on the grounds of traditional use of the medical devices. RF generators may register fastest growing CAGR in the next five years due to rising instances of radiofrequency ablation being the most preferred method to treat, that also substantiating the growth of the United Kingdom renal denervation market in the forecast years through 2027F.
Based on therapeutic area, the market is differentiated into hypertension, heart failure, diabetes, renal failure, and others. Hypertension is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to increasing instances of the disorder among the population. Heart failure may also hold significant shares of the market due to rising instances of the cardiovascular diseases rising in the country. Diabetes may register fastest growth due to sedentary lifestyle among the population and their exceeding consumption of fast food and junk food consistently.
By end user, the market is further bifurcated into hospitals & clinics, ambulatory care centers, and other. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside.
A partial list of major market players of the United Kingdom renal denervation market includes:
- Medtronic United Kingdom
- Boston Scientific Limited
- Abbott Laboratories Limited
- CardioSonic Limited
- Terumo UK Limited
- Johnson & Johnson Limited
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=10634
Customers can also request for 10% free customization on this report.
“Hospitals & clinics are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the grounds of increasing patient count suffering from hypertension and high blood pressure problems. Availability of the medical devices, technology and in-expensive equipment and healthcare services further fuels the growth of the market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United Kingdom Renal Denervation Market By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others), By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027” has evaluated the future growth potential of United Kingdom renal denervation market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United Kingdom renal denervation market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]